.png){kind=icon}
.png){kind=icon}
Return
Correction: Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent Endometrial Cancer: A Nationwide Cohort Study in France
.png){kind=icon}
OA
AI
A
S
D
M
N
DOI：10.1007/s40259-026-00778-w.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
6.9
Papers:
1.6K
Citations:
3.5K
Organization
Cited Papers